Rather than relying on a third-party view from a doctor or nurse, patient-reported outcomes provide a real-world assessment of healthcare’s effectiveness from those experiencing it firsthand.
One goal of FocalView is to create a more accurate way to track and measure disease progression and develop more sensitive clinical trial endpoints from the comfort of patients' homes., adding more flexibility to clinical trial design.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.